Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS -1.95%·Rev n/aQ3 24EPS -2.04%·Rev n/aQ2 24EPS +25.33%·Rev n/aQ1 24EPS +31.65%·Rev n/a⚠ consensus missing

Amphastar Pharmaceuticals, Inc. AMPH

Dan Dischner — Head of Investor Relations

William Peters — Chief Financial Officer and Executive Vice President of Finance

−9.7%1d on move date−11.3% vs SPY3d−12.3%5d−10.1%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMPH calls or request research access.

More AMPH calls Browse calls Request research access